Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Efficient and irreversible antibody-cysteine bioconjugation using carbonylacrylic reagents

Texto completo
Autor(es):
Bernardim, Barbara [1, 2] ; Matos, Maria J. [2] ; Ferhati, Xhenti [3] ; Companon, Ismael [3] ; Guerreiro, Ana [4] ; Akkapeddi, Padma [4] ; Burtoloso, Antonio C. B. [5] ; Jimenez-Oses, Gonzalo [3] ; Corzana, Francisco [3] ; Bernardes, Goncalo J. L. [4, 2]
Número total de Autores: 10
Afiliação do(s) autor(es):
[1] Univ Fed Sao Carlos, Dept Quim, Sao Carlos, SP - Brazil
[2] Univ Cambridge, Dept Chem, Cambridge - England
[3] Univ La Rioja, Dept Quim, Ctr Invest Sintesis Quim, Logrono - Spain
[4] Univ Lisbon, Inst Med Mol, Fac Med, Lisbon - Portugal
[5] Univ Sao Paulo, Inst Quim Sao Carlos, Sao Carlos, SP - Brazil
Número total de Afiliações: 5
Tipo de documento: Artigo Científico
Fonte: Nature Protocols; v. 14, n. 1, p. 86-99, JAN 2019.
Citações Web of Science: 2
Resumo

There is considerable interest in the development of chemical methods for the precise, site-selective modification of antibodies for therapeutic applications. In this protocol, we describe a strategy for the irreversible and selective modification of cysteine residues on antibodies, using functionalized carbonylacrylic reagents. This protocol is based on a thiol-Michael-type addition of native or engineered cysteine residues to carbonylacrylic reagents equipped with functional compounds such as cytotoxic drugs. This approach is a robust alternative to the conventional maleimide technique; the reaction is irreversible and uses synthetically accessible reagents. Complete conversion to the conjugates, with improved quality and homogeneity, is often achieved using a minimal excess (typically between 5 and 10 equiv.) of the carbonylacrylic reagent. Potential applications of this method cover a broad scope of cysteine-tagged antibodies in various formats (full-length IgGs, nanobodies) for the site-selective incorporation of cytotoxic drugs without loss of antigen-binding affinity. Both the synthesis of the carbonylacrylic reagent armed with a synthetic molecule of interest and the subsequent preparation of the chemically defined, homogeneous antibody conjugate can be achieved within 48 h and can be easily performed by nonspecialists. Importantly, the conjugates formed are stable in human plasma. The use of liquid chromatography-mass spectrometry (LC-MS) analysis is recommended for monitoring the progression of the bioconjugation reactions on protein and antibody substrates with accurate resolution. (AU)

Processo FAPESP: 13/25504-1 - Desenvolvimento de novas metodologias para a-funcionalização assimétrica de compostos carbonílicos utilizando catalisadores quirais
Beneficiário:Antonio Carlos Bender Burtoloso
Linha de fomento: Auxílio à Pesquisa - Regular
Processo FAPESP: 15/07509-1 - Modificação específica de proteínas via reação de Horner-Wadsworth-Emmons seguida de rearranjo de Wolff
Beneficiário:Barbara Bernardim de Souza
Linha de fomento: Bolsas no Exterior - Estágio de Pesquisa - Doutorado
Processo FAPESP: 17/13168-8 - Construção de conjugados anticorpo-droga quimicamente definidos utilizando reagentes carbonilacrílicos
Beneficiário:Barbara Bernardim de Souza
Linha de fomento: Bolsas no Exterior - Estágio de Pesquisa - Pós-Doutorado